Evoq Therapeutics-preview

Evoqtherapeutics

Evoq Therapeutics

Private

Ann Arbor, MichiganHealthcare & Life Scienceshttps://www.evoqtherapeutics.com/

Last Round

Grant

Aug 29, 2024

Total Funding Raised

$6.73M

Momentum Score

75 /100

Company Overview

Evoq Therapeutics is a biotechnology company that is developing a pipeline of disease-specific immune modulators to treat patients afflicted with autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

autoimmune immunotherapyNanoDisc platformimmune toleranceantigen delivery platformnanomedicinetechnology licensingbiotech platform companytolerogenic immunotherapyantigen-specific immunotherapynanoparticle drug deliveryHDL nanoparticlesType 1 Diabetes immunotherapyCeliac Disease therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evoq Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Evoq Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Aug 29, 2024
Grant	Oct 14, 2022
Convertible Debt	Oct 25, 2021
Grant	Nov 13, 2019
Seed	Nov 5, 2018
Debt	Sep 8, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

David Giljohann

Chief Executive Officer

Executive Team

Evoq Therapeutics Investors

Notable investors and investment history

Investor	Rounds
Invest Detroit	Seed, Grant
Ralph C. Wilson, Jr. Foundation	Grant
NIH RADx	Grant
Ann Arbor SPARK	Grant, Convertible Debt, Debt
BELLE Impact Fund	Grant
Forbes Institute for Cancer Discovery	Grant
William Davidson Foundation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 22, 2026
Grew 30% QoQ from 10 to 13 employees.
Apr 16, 2026
Monthly visitors grew 138% MoM, reaching 2.1K.

View all signals

Evoq Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Evoq Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evoq Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAnn Arbor, Michigan

Employee Range13

Year Founded2016

Last FundingAug 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.